SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
pages: 1 2
|
presentations:
1 to
50 of
83
|
HIV CURE FROM BENCH TO BEDSIDE (ABSTRACT
17)
Sharon R. Lewin
University of Melbourne, Melbourne, Victoria, Australia
UNIVERSAL TEST AND TREAT (UTT): LESSONS FROM THE PAST AND FOR THE FUTURE (ABSTRACT
18)
Kevin M. De Cock
Centers for Disease Control and Prevention, Nairobi, Kenya
INDEX FACTORS INCREASE PARTNER NOTIFICATION YIELD FOR KENYAN PEOPLE WHO INJECT DRUGS (ABSTRACT
42)
Brandon Guthrie
University of Washington, Seattle, WA, USA
COMMUNITY-BASED MULTIMONTH DISPENSING OF ART: A CLUSTER RANDOMISED TRIAL IN LESOTHO (ABSTRACT
43)
Betty Bawuba Tukei
Right to Care, Maseru, Lesotho
AN MHEALTH CHW INTERVENTION TRIAL IN AN HIV HYPERENDEMIC COMMUNITY IN RAKAI, UGANDA (ABSTRACT
44)
Larry W Chang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
IMPROVED TIME IN CARE AND VIRAL SUPPRESSION WITH STREAMLINED CARE IN THE SEARCH STUDY (ABSTRACT
45)
Matthew D Hickey
University of California San Francisco, San Francisco, CA, USA
COLLABORATIVE DATA-TO-CARE MODEL IMPROVES HIV CARE OUTCOMES IN PLWH IN PHILADELPHIA (ABSTRACT
46)
Kathleen Anne Brady
Philadelphia Department of Public Health, Philadelphia, PA, USA
POPULATION-LEVEL VIREMIA PREDICTS HIV INCIDENCE ACROSS UNIVERSAL TEST & TREAT STUDIES (ABSTRACT
47)
Maya L Petersen
University of California, Berkeley, Berkeley, CA, USA
DECREASING COMMUNITY VIREMIA IS ASSOCIATED WITH DECREASING HIV INCIDENCE IN AUSTRALIA (ABSTRACT
48)
Denton James Callander
UNSW Sydney, Sydney, NSW, Australia
COMMUNITY ART INCREASES VIRAL SUPPRESSION AND ELIMINATES DISPARITIES FOR AFRICAN MEN (ABSTRACT
49)
Ruanne V Barnabas
University of Washington, Seattle, WA, USA
SINGLE-CELL GENOMIC ANALYSIS OF BLOOD AND CSF T CELLS IN HIV+ AND HIV– ADULTS (ABSTRACT
27)
Shelli Farhadian
Yale School of Medicine, New Haven, CT, USA
GREATER BURDEN OF INTRACRANIAL ARTERIAL-WALL ENHANCEMENT IN PERSONS LIVING WITH HIV (ABSTRACT
28)
Felicia C Chow
University of California San Francisco, San Francisco, CA, USA
PET IMAGING OF SYNAPTIC DENSITY IN HIV: PRELIMINARY FINDINGS FROM A PILOT STUDY (ABSTRACT
29)
Julian Weiss
Yale University, New Haven, CT, USA
HIV-INFECTED MACROPHAGES EVADE NK CELL-MEDIATED KILLING WHILE DRIVING INFLAMMATION (ABSTRACT
30)
Kiera L Clayton
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
HIV DNA DETECTED IN IMMUNE CELL SUBSETS IN CSF DURING ART (ABSTRACT
31)
Joshua Charles Cyktor
University of Pittsburgh, Pittsburgh, PA, USA
EFFECTS OF HIV AND AGING ON RESTING-STATE NETWORKS (ABSTRACT
32)
Patrick Luckett
Washington University in St Louis, St Louis, MO, USA
MYELIN CONTENT IS ELEVATED IN VIROLOGICALLY UNSUPPRESSED PEOPLE LIVING WITH HIV (ABSTRACT
33)
Dimitre Tomov
Washington University, St Louis, MO, USA
CABOTEGRAVIR + RILPIVIRINE EVERY 2 MONTHS IS NONINFERIOR TO MONTHLY: ATLAS-2M STUDY (ABSTRACT
34)
Edgar Turner Overton
University of Alabama, Birmingham, AL, USA
PROSPECTIVE ENHANCED MONITORING OF DOLUTEGRAVIR-BASED FIRST LINE IN MALAWI (ABSTRACT
35)
Elvis Temfack
Medecins Sans Frontieres, Blantyre, Malawi
RANDOMIZED SWITCH TO B/F/TAF IN AFRICAN AMERICAN ADULTS WITH HIV (ABSTRACT
36)
Debbie P Hagins
Chatham CARE Center, Savannah, GA, USA
IMPACT OF ANTI-PD-1 AND ANTI-CTLA-4 ON THE HIV RESERVOIR IN VIVO: THE AMC-095 STUDY (ABSTRACT
37)
Thomas Aagaard Rasmussen
University of Melbourne, Melbourne, Victoria, Australia
A RANDOMIZED TRIAL OF THE IMPACT OF 3BNC117 AND ROMIDEPSIN ON THE HIV-1 RESERVOIR (ABSTRACT
38)
Ole Schmeltz Søgaard
Aarhus University Hospital, Aarhus N, Denmark
SAFETY & PHARMACOKINETICS OF GS-9722 IN HIV-NEGATIVE PARTICIPANTS AND PEOPLE WITH HIV (ABSTRACT
39)
Peter Ruane
Peter J Ruane, MD Inc, Los Angeles, CA, USA
SAFETY AND ANALYTIC TREATMENT INTERRUPTION OUTCOMES OF VESATOLIMOD IN HIV CONTROLLERS (ABSTRACT
40)
Devi Sengupta
Gilead Sciences, Foster City, CA, USA
DURABLE HIV-1 ANTIBODY PRODUCTION IN HUMANS AFTER AAV8-MEDIATED GENE TRANSFER (ABSTRACT
41)
Joseph P Casazza
National Institutes of Health, USA, Bethesda, MD, USA
MECHANISMS OF PSGL-1 AND CD43 RESTRICTION OF HIV INFECTION OF CD4 T CELLS (ABSTRACT
19)
Yuntao Wu
George Mason University, Manassas, VA, USA
STRUCTURAL ANALYSES OF A BOUND ANTI-CD4 ADNECTIN INHIBITOR OF HIV-1 (ABSTRACT
20)
David Wensel
ViiV Healthcare, Branford, CT, USA
SERINC3/5 PERTURB HIV MEMBRANE FUSION POST-HEMIFUSION AT FUSION-PORE DILATION STEPS (ABSTRACT
21)
Amanda E Ward
University of Virginia, Charlottesville, VA, USA
CRISPR-INDUCED MUTAGENESIS POINTS TOWARD A ROLE OF TRN-SR2 IN HIV NUCLEAR IMPORT (ABSTRACT
22)
Frauke Christ
Katholieke University Leuven, Leuven, Belgium
NUCLEAR UNCOATING OF HIV-1 OCCURS NEAR SITES OF INTEGRATION (ABSTRACT
23)
Ryan C Burdick
National Cancer Institute, Frederick, MD, USA
RECONSTITUTION OF HIV-1 CAPSID-DEPENDENT REPLICATION AND INTEGRATION IN VITRO (ABSTRACT
24)
Devin E Christensen
University of Utah, Salt Lake City, UT, USA
STRUCTURAL BASIS OF SECOND-GENERATION HIV INTEGRASE INHIBITOR ACTION AND VIRUS ESCAPE (ABSTRACT
25)
Peter Cherepanov
Francis Crick Institute, London, United Kingdom
THE CHROMATIN LANDSCAPE AT THE HIV-1 INTEGRATION SITE DETERMINES VIRAL EXPRESSION (ABSTRACT
26)
Zeger Debyser
KU Leuven, Leuven, Belgium
SESSION INTRODUCTION
Risa M. Hoffman
David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA
CHANGES IN BONE MINERAL DURING AND AFTER LACTATION IN UGANDAN WOMEN ON OPTION B+ ART (ABSTRACT
768)
Mary Glenn Fowler
Johns Hopkins University, Baltimore, MD, USA
POSTPARTUM WEIGHT CHANGES IN WOMEN INITIATING DTG VS EFV IN PREGNANCY: DOLPHIN-2 (ABSTRACT
771)
Thokozile Rosemary Malaba
University of Cape Town, Cape Town, South Africa
DOLUTEGRAVIR USE IS ASSOCIATED WITH HIGHER POSTPARTUM WEIGHT COMPARED TO EFAVIRENZ (ABSTRACT
772)
Jennifer Jao
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
FACTORS ASSOCIATED WITH GESTATIONAL DIABETES IN HIV+ AND HIV– WOMEN IN PUNE, INDIA (ABSTRACT
774)
Puja Chebrolu
Weill Cornell Medicine, Columbus, GA, USA
HIGH BLOOD PRESSURE AND ADVERSE BIRTH OUTCOMES IN HIV+ AND HIV– SOUTH AFRICAN WOMEN (ABSTRACT
769)
Angela Bengtson
Brown University, Providence, RI, USA
SESSION INTRODUCTION
Markella V Zanni
Massachusetts General Hospital, Boston, MA, USA
TESTOSTERONE THERAPY AND SUBCLINICAL ATHEROSCLEROSIS PROGRESSION AMONG MEN WITH HIV (ABSTRACT
642)
Sabina A. Haberlen
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
POSTDISCHARGE OUTCOMES FOLLOWING ACUTE CORONARY SYNDROME IN HIV (ABSTRACT
643)
Monica Parks
University of California San Francisco, San Francisco, CA, USA
INSOMNIA AND RISK OF INCIDENT MYOCARDIAL INFARCTION AMONG PEOPLE LIVING WITH HIV (ABSTRACT
644)
Bridget M Whitney
University of Washington, Seattle, WA, USA
HORMONE USE AND HIV ALTER CARDIOVASCULAR BIOMARKER PROFILES IN TRANSGENDER WOMEN (ABSTRACT
645)
Jordan E Lake
University of Texas Health Science Center Houston, Houston, TX, USA
HIV SEVERITY AND INCIDENT HEART FAILURE AMONG PATIENTS IN A LARGE HEALTH CARE SYSTEM (ABSTRACT
646)
Jennifer O. Lam
Kaiser Permanente, Oakland, CA, USA
SESSION INTRODUCTION
Rachel Baggaley
World Health Organization, Geneva, Switzerland
ASSISTED PARTNER NOTIFICATION SERVICES IN KAMPALA, UGANDA (ABSTRACT
937)
Florence Namimbi
Infectious Diseases Institute, Kampala, Uganda
TARGETED PEER MOBILISATION AND ASSISTED PARTNER NOTIFICATION SERVICES IN KENYA (ABSTRACT
938)
Maartje Dijkstra
Public Health Service Amsterdam, Amsterdam, NE, Netherlands
SCALE-UP OF ASSISTED PARTNER SERVICES (APS) IN BOTSWANA (ABSTRACT
939)
Matthew R Golden
University of Washington, Seattle, WA, USA
OPTIMIZING TESTING INCREASES YIELD IN HIV CASE FINDING IN 24 COUNTRIES, 2018–2019 (ABSTRACT
940)
Shahul Hameed Ebrahim
Centers for Disease Control, atlanta, GA, USA
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
pages: 1 2
|
presentations:
1 to
50 of
83
|